SFU
IRWD icon

Stonehage Fleming (UK)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Stonehage Fleming (UK)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$16K Buy
+1,910
New +$18.5K 0.01% 203

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Stonehage Fleming (UK)'s IRWD Position: Q4 2015 in Review

Stonehage Fleming (UK) opened a new position in Ironwood Pharmaceuticals (IRWD) in Q4 2015: 1,910 shares worth $16K. The stake represents 0.01% of the portfolio and ranks #203 among its holdings.

137 funds tracked by Wall St. Rank hold IRWD as of Q4 2015.

  • Stonehage Fleming (UK) held 1,910 shares of Ironwood Pharmaceuticals worth $16K as of Q4 2015.
  • Ironwood Pharmaceuticals was a new Stonehage Fleming (UK) position in Q4 2015.
  • Ironwood Pharmaceuticals made up 0.01% of Stonehage Fleming (UK)'s portfolio in Q4 2015, its #203 holding.
  • 137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2015, filed 11 Oct 2019.